Viridescent Concoction of Genstein Tendentious silver Nanoparticles for Breast Cancer

Author:

Singh Aditya1,Ansari Vaseem A.1,Ahsan Farogh1,Akhtar Juber1,Khushwaha Poonam1,Maheshwari Shubhrat2,Rufaida Rufaida1

Affiliation:

1. Faculty of Pharmacy, Integral University, Lucknow India.

2. Shri Ram Murti Smarak College of Engineering and Technology, Pharmacy Bareilly India.

Abstract

Cancer predicament is a global concern because of the ability of swift growth to cause infection to the cell. Breast cancer is the fifth contemplative reason for cancer death many scientific approaches have been thriving to deal with it and to make anticancer agent, therapeutic, safe and effective. In this burgeon silver was found as antitumor agent with noteworthy properties of conductivity, stability, and activity. Soy isoflavones mainly derived from soybean have accure much attention as dietary components having inhibitory effects on breast cancer and prostate cancer in Asians, who consume 20-50 times more than Americans, soy diet act as a natural chemopreventive agent. Previous data show that nanoparticles of silver are effective against a wide spectrum of bacteria, fungi, viruses, some infectious diseases and burn wounds. Now genistein has been found to inhibit the growth of various cancer cell lines including prostate and breast cancer cells. Nanoparticles needed to be biosynthesized because of the expensive, physical and. chemical processes. Chemical synthesis also contributes to the appearance on the surface of some toxic chemical that can adversely affect medical applications. Green synthesis offers advances over chemical and physical method because it is price effective, environmentally friendly, easily scaled up for large scale synthesis and does not requires use high pressure, energy, temperature and toxic chemicals.

Publisher

A and V Publications

Subject

Pharmacology (medical),Pharmacology, Toxicology and Pharmaceutics (miscellaneous)

Reference62 articles.

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3